IV Medications Elsevier Downloads & RevenueIV Medications Elsevier · App Store
IV Medications Elsevier is #15 in Medical Grossing in Indonesia and charting in 1 of 30 countries we track.
Updated 8 Nov 2026 · rankings refresh through the day
DeveloperSkyscape Medpresso Inc
CategoryMedical
PriceFree
Released
Rating★ 0.0 (0)
Version5.10.0
Age rating17+
First seen by us
3 Nov 2026
3 Nov 2026Installs (est.)5k+ worldwide
IV Medications Elsevier update history & changes
Last change · 5 events since 25 Jan 2017Full timeline ↓📦First update in 291 days📦Updated to version 5.10.0🆕First spotted by AppInsider🆕Released on the App Store
Full timeline · 5 events
- 📦IV Medications Elsevier: first update in 291 days
- 📦IV Medications Elsevier updated to version 5.10.02027 update based on Elsevier’s 2027 Intravenous Medications, 43rd Edition. Includes monographs for approximately 10–20 newly approved IV drugs, updated drug uses, interactions, precautions, alerts, and patient teaching instructions for current IV drugs, plus QR codes for additional drug monographs for quick point-of-care access. Supports safe IV medication administration with dosing, dilution, compatibility, infusion-rate, contraindication, interaction, side-effect, antidote, and life-stage dosage variance information.… more
- 🆕IV Medications Elsevier first spotted by AppInsider#1 in Top Grossing · Medical · Indonesia (found via search)
- 📦IV Medications Elsevier version 5.8.5- Minor Bug Fixes
- 🆕IV Medications Elsevier released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
0.0 ★
0 ratings
Measured
Best rank now
#15
Medical GrossingMeasured
IV Medications Elsevier at a glance
AI summary written from our chart and store data, 2026-11-07. It can be wrong: check the numbers above.
A freemium medical reference app providing detailed monographs for over 400 intravenous drugs, designed for nurses, pharmacists, and physicians to support safe medication administration at the point of care. The app currently holds the #1 position in the Indonesia Medical Grossing chart, indicating strong commercial traction despite its free-to-download model requiring in-app purchases for full access.
Similar apps: UpToDate, Epocrates, Micromedex
IV Medications Elsevier on the App Store
App details
App ID
1143476433
Publisher
Skyscape Medpresso Inc
On the store since
Jan 2017
9 years on the store
Minimum OS
iOS 15.0+
iPhone 6s and later
Devices
iPhone · iPad
Universal purchase
Content rating
17+
2 content notes below
Languages
1
EN
Size
48 MB
Also listed in
Education
Content notesFrequent/Intense Medical/Treatment InformationInfrequent/Mild Alcohol, Tobacco, or Drug Use or References
App privacy Measured
IV Medications Elsevier’s App Store privacy label declares 1 data category used to track you across other companies’ apps and websites, 0 linked to your identity and 5 collected anonymously.
Used to track you
1
Linked to you
0
Not linked to you
5
Tracks you via
IIdentifiers
Not linked to you
UUser Content+4 more
As declared by the developer on the App Store — Apple requires every app to publish this label. We track changes over time.
IV Medications Elsevier downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Apple publishes no download counts. App Store downloads come from chart positions and daily rating growth per country, calibrated on Google Play install counts; lifetime installs from ratings worldwide × installs per rating. Confidence is the chance the real number is within half to double ours.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
In-app revenue
Worldwide, what users spend in IV Medications Elsevier before Apple and Google take their fee.
How this is calculated
Not in an overall Top Grossing chart, only in category charts: each category position is converted to the overall position it corresponds to, then priced on the same rank-to-revenue curve, inside the part of each market the charted apps leave over.
Business model: Subscription-led
How IV Medications Elsevier makes money: subscriptions, one-off purchases and ads.
SubscriptionsIn-app purchasesAds · 3 ad networks
Subscriptions
/mo
of revenue
Ads
/mo
of revenue
Top in-app purchases · App Store US, most popular first
| 1 | Elsevier’s IV Med HBK 1Y Sub subscription | |
| 2 | Elsevier’s IV Med HBK 3/M Sub subscription | |
| 3 | Elsevier’s IV Med HBK 6M Sub subscription | |
| 4 | 25% Off-Elsevier IVMed 1Y Sub | |
| 5 | 20% Off-Elsevier IVMed 1Y Sub | |
| 6 | 15% Off-Elsevier IVMed 1Y Sub | |
| 7 | Elsevier IV Med HBK 1Y Sub off | |
| 8 | Intravenous Medications 2022 |
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Indonesia | MedicalGrossing | #15 |
Apps near IV Medications Elsevier on the chart
Medical Grossing, around #15.
Ratings
App Store, worldwide.
Rating
0.0 ★
0 ratings
Measured
Ratings
0
Measured
What users say about IV Medications Elsevier
From recent reviews.
About IV Medications Elsevier
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
**Elsevier’s Intravenous Medications 2027, 43rd Edition – App**
Get quick access to essential information for the safe administration of more than 400 intravenous (IV) drugs with the *Elsevier’s Intravenous Medications 2027, 43rd Edition* app. Trusted for more than 50 years, this digital reference is designed for nurses, pharmacists, physicians, and other clinicians who need reliable drug information at the point of care.
Organized alphabetically by generic drug name, the app provides concise, detailed drug monographs for quick reference. Each monograph includes drug name, phonetic pronunciation, usual dosage, dilution, compatibility, administration rate, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
The 2027 edition adds approximately 10–20 monographs for newly FDA-approved IV drugs, along with updates to drug uses, interactions, precautions, alerts, and patient teaching instructions to support safer medication practices.
**Selected for 2026 Doody’s Core Titles as an Essential Purchase in Medical/Surgical.**
### Key Features
- **400+ IV drugs:** Extensive drug coverage for everyday clinical needs.
- **Quick A-to-Z navigation:** Find drug monographs by generic name.
- **Comprehensive information:** Review dosage, dilution, compatibility, administration rates, indications, contraindications, interactions, side effects, and antidotes.
- **Clinically optimized layout:** Dosage information appears on a single page or two-page spread, minimizing page turning.
- **Black Box Warnings:** Easily identify important warnings about medications associated with serious risks.
- **Highlighted precautions:** Blue-screened text draws attention to additional safety information.
- **Dosage and dilution charts:** Quickly review essential clinical details.
- **Life-stage dosage guidance:** Highlighted dosage variations cover geriatric, pediatric, infant, and neonatal patients.
- **Additional online resources:** QR codes provide access to supplementary drug information, including additional monographs available through Evolve.
### Essential IV Drug Information at Your Fingertips
Designed for healthcare professionals in critical care, hospitals, clinics, nursing stations, public health, and home care settings, this app provides convenient digital access to trusted IV medication information.
Whether checking dosage, reviewing dilution and compatibility, verifying administration rates, or identifying precautions and potential interactions, the app helps clinicians find essential information quickly to support informed decisions and safer IV medication practices.
Content licensed from printed edition ISBN 10: 0443433364, ISBN 13: 9780443433368
SUBSCRIPTION :
Please choose an auto renewable subscription plan to receive content access and continuous updates. Your subscription a
**Elsevier’s Intravenous Medications 2027, 43rd Edition – App**
Get quick access to essential information for the safe administration of more than 400 intravenous (IV) drugs with the *Elsevier’s Intravenous Medications 2027, 43rd Edition* app. Trusted for more than 50 years, this digital reference is designed for nurses, pharmacists, physicians, and other clinicians who need reliable drug information at the point of care.
Organized alphabetically by generic drug name, the app provides concise, detailed drug monographs for quick reference. Each monograph includes drug name, phonetic pronunciation, usual dosage, dilution, compatibility, administration rate, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
The 2027 edition adds approximately 10–20 monographs for newly FDA-approved IV drugs, along with updates to drug uses, interactions, precautions, alerts, and patient teaching instructions to support safer medication practices.
**Selected for 2026 Doody’s Core Titles as an Essential Purchase in Medical/Surgical.**
### Key Features
- **400+ IV drugs:** Extensive drug coverage for everyday clinical needs.
- **Quick A-to-Z navigation:** Find drug monographs by generic name.
- **Comprehensive information:** Review dosage, dilution, compatibility, administration rates, indications, contraindications, interactions, side effects, and antidotes.
- **Clinically optimized layout:** Dosage information appears on a single page or two-page spread, minimizing page turning.
- **Black Box Warnings:** Easily identify important warnings about medications associated with serious risks.
- **Highlighted precautions:** Blue-screened text draws attention to additional safety information.
- **Dosage and dilution charts:** Quickly review essential clinical details.
- **Life-stage dosage guidance:** Highlighted dosage variations cover geriatric, pediatric, infant, and neonatal patients.
- **Additional online resources:** QR codes provide access to supplementary drug information, including additional monographs available through Evolve.
### Essential IV Drug Information at Your Fingertips
Designed for healthcare professionals in critical care, hospitals, clinics, nursing stations, public health, and home care settings, this app provides convenient digital access to trusted IV medication information.
Whether checking dosage, reviewing dilution and compatibility, verifying administration rates, or identifying precautions and potential interactions, the app helps clinicians find essential information quickly to support informed decisions and safer IV medication practices.
Content licensed from printed edition ISBN 10: 0443433364, ISBN 13: 9780443433368
SUBSCRIPTION :
Please choose an auto renewable subscription plan to receive content access and continuous updates. Your subscription a
Latest updates
5.10.0
2027 update based on Elsevier’s 2027 Intravenous Medications, 43rd Edition. Includes monographs for approximately 10–20 newly approved IV drugs, updated drug uses, interactions, precautions, alerts, and patient teaching instructions for current IV drugs, plus QR codes for additional drug monographs for quick point-of-care access. Supports safe IV medication administration with dosing, dilution, compatibility, infusion-rate, contraindication, interaction, side-effect, antidote, and life-stage dosage variance information.
5.8.5
- Minor Bug Fixes
More from Skyscape Medpresso Inc
AHFS Drug Information
5 Minute Pediatric Consult +
Saunders Nursing Drug Handbook
Harriet Lane Handbook App
Drugs in Pregnancy Lactation
Medical Surgical Nursing Lewis
Netters Anatomy Flash Cards
Oncology Nursing Drug Handbook
Hematology & Oncology Consult
Saunders Comp Review NCLEX RN
Davis’s Canadian Drug Guide
The Wills Eye Manual